Pfizer Buys into Brazilian Drug Maker Teuto

Oct. 20, 2010
Boosting presence in emerging markets

Pfizer said on Oct. 20 that it has bought 40% of Brazilian drug company Teuto for $238 million as part of its strategy to boost its presence in emerging markets.

The purchase could lead to the 100% acquisition of Teuto in 2014, the company said.

The stake "allows Pfizer to increase its participation in Brazil's pharmaceutical market," the head of Pfizer Brazil, Victor Mezei said. He explained that the deal could result in Teuto producing generic versions of Pfizer medicines, and Pfizer using Teuto products in its output.

The maker of Viagra and Lipitor had 2009 revenues of $50 billion and profits of $8.6 billion.

Copyright Agence France-Presse, 2010

Continue Reading

Popular Sponsored Recommendations

Why DataOps may be the key to unlocking the full potential of digital transformation

Nov. 3, 2023
Read the 2023 market survey conducted by IndustryWeek

Discrete and Process Manufacturing 2024 Trends and Outlook for North America

Oct. 29, 2023
Manufacturers are reaping the benefits of automation and cloud-based solutions. Discover what is driving today's industry trends and how they can shape your growth priorities ...

Decarbonization Navigator: A Toolkit for Organizations

Sept. 28, 2023
The increasing urgency of addressing climate change along with stakeholder pressures are driving the need for organizations to prioritize decarbonization. Discover how to start...

Digitally Transforming Data and Processes With Product Lifecycle Management

Oct. 29, 2023
Manufacturers face increasing challenges in product development as they strive to consistently deliver improved results. Discover how industry leaders are improving time-to-market...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!